Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 42kWORD 9k
5 February 2020
Question for written answer
to the Commission
Rule 138
Alessandra Moretti, Patrizia Toia, Giuseppe Ferrandino, Pietro Bartolo, Brando Benifei, Nicola Danti, Giuliano Pisapia, Elisabetta Gualmini, Irene Tinagli, Caterina Chinnici
 Answer in writing 
 Subject: Coronavirus

On 31 December 2019, the Wuhan Health Commission reported to the WHO a cluster of pneumonia cases of unknown aetiology in Wuhan City. On 9 January 2020, the Chinese Centre for Disease Control reported that a new coronavirus had been identified as a causative agent and the genome sequence was made available to the public.

To date, there is no vaccine available, as it is currently at the testing stage.

The WHO has recommended exit screening at airports as part of a full set of containment measures and, on 30 January, declared the coronavirus epidemic in China a public health emergency of international concern; the Italian Government did the same on 31 January.

Can the Commission therefore answer the following questions:

What measures does it intend to take to curb the spread of the virus within the EU?

Will it set up a specific fund for research into new vaccines?

Will it work together with the WHO, the European Centre for Disease Prevention and Control and national authorities to take measures to ensure the uniformity of controls and a common protocol?

Last updated: 19 February 2020Legal notice - Privacy policy